VX1 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Vertex Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 362.95 EUR 0.67%

Market Cap: €43.4B

V	Vertex Pharmaceuticals Inc XMUN:VX1	US
	Opthea Ltd F:UKJ	AU
C	China Pacific Insurance Group Co Ltd XBER:75C	CN
K	Kimberly-Clark Corp F:KMY	US
	UWM Holdings Corp NYSE:UWMC	US
T	Trigano SA SWB:TGO	FR
	Bidvest Group Ltd F:NQL	ZA
	ASR Nederland NV F:A16	NL
	AngloGold Ashanti Ltd F:AOD1	ZA
	Bureau Veritas SA LSE:0MH1	FR
E	Eastman Chemical Co XMUN:EAC	US
O	Oversea-Chinese Banking Corporation Ltd F:OCBA	SG
	Aspen Pharmacare Holdings Ltd F:LDZU	ZA
	CK Asset Holdings Ltd OTC:CNGKY	HK
G	General Motors Co F:8GM	US

Profitability Summary

Vertex Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

86%

Strong 3Y Average Gross Margin

87%

Declining Gross Margin

88% > 86%

Exceptional Operating Margin

39%

Strong 3Y Average Operating Margin

42%

Declining Operating Margin

49% > 39%

Exceptional Net Margin

33%

Sustainable 3Y Average Net Margin

21%

Declining Net Margin

35% > 33%

Exceptional Free Cash Flow Margin

27%

Strong 3Y Average Free Cash Flow Margin

19%

Declining Free Cash Flow Margin

42% > 27%

Positive ROE

23%

Positive 3Y Average ROE

Positive 3Y Average ROIC

14%

Declining ROIC

50% > 27%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.